New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
10:43 EDTGALT, CYTK, EXAS, CONN, RHOptions with decreasing implied volatility: GALT CYTK EXAS CONN RH
News For GALT;CYTK;EXAS;CONN;RH From The Last 14 Days
Check below for free stories on GALT;CYTK;EXAS;CONN;RH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
11:18 EDTRHWilliams-Sonoma plunges as FY14 outlook falls below analysts' expectations
Subscribe for More Information
06:29 EDTCONNConn's September volatility elevated into Q2 and outlook
Conn's September call option implied volatility is at 65, October is at 53, January is at 46; compared to its 26-week average of 58 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on September 2.
August 27, 2014
09:32 EDTEXASExact Sciences management to meet with Roth Capital
Meeting to be held in Boston on September 3 hosted by Roth Capital.
08:00 EDTEXASExact Sciences price target raised to $28 from $22 at JMP Securities
JMP Securities increased its price target on Exact Sciences as the firm, after conducting channel checks, estimates that ColoGuard will sell for $375. The firm continues to recommend buying shares of the stock.
August 26, 2014
07:46 EDTEXASExact Sciences price target raised to $23 from $21 at Canaccord
Canaccord raised its price target on Exact Sciences to $23 from $21 following yesterday's announcement the Mayo Clinic will adopt Cologuard. The firm believes there is the potential for additional healthcare systems to come on board as the publicity raises awareness among primary care doctors. Canaccord keeps its Buy rating on shares of Exact Sciences.
August 25, 2014
11:26 EDTEXASOptions with increasing implied volatility: EXAS FTR PSEC
Subscribe for More Information
August 22, 2014
13:31 EDTEXASExact Sciences test not reimbursed by Aetna, says Maxim
Subscribe for More Information
10:07 EDTEXASOptions with increasing implied volatility: ORPH EXAS AZN
Subscribe for More Information
August 20, 2014
11:47 EDTEXASOptions with increasing implied volatilit
Subscribe for More Information
August 18, 2014
08:05 EDTEXASExact Sciences risk/reward positive, says Canaccord
Canaccord said the scenario analysis of upcoming catalysts suggests positive risk/reward for the shares of Exact Sciences. The firm cited its potential for reimbursement approvals form both the CMS and commercial payers. Shares of Exact Sciences remain Buy rated with a $21 price target.
August 14, 2014
17:00 EDTCONNGreenlight Capital gives quarterly update on stakes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use